Documentdetail
ID kaart

oai:arXiv.org:2408.06148

Onderwerp
Computer Science - Software Engine...
Auteur
Garousi, Vahid Keleş, Alper Buğra Balaman, Yunus Mermer, Alper Güler, Zeynep Özdemir
Categorie

Computer Science

Jaar

2024

vermelding datum

14-08-2024

Trefwoorden
mbt code-coverage requirements test tool
Metriek

Beschrijving

There are many widely used tools for measuring test-coverage and code-coverage.

Test coverage is the ratio of requirements or other non-code artifacts covered by a test suite, while code-coverage is the ratio of source code covered by tests.

Almost all coverage tools show a few certain subset of coverage values, and almost always either test-coverage or code-coverage measures.

In a large-scale industrial web-application-testing setting, we were faced with the need to "integrate" several types of coverage data (including front-end and back-end code coverage with requirements coverage), and to see all of them "live" as large model-based test suites were running.

By being unable to find any off-the-shelf toolset to address the above need, we have developed an open-source test coverage tool, specific for MBT, named MBTCover.

In addition to code coverage, the tool measures and reports requirements and model coverage, "live" as a given MBT test suite is executing.

In this paper, we present the features of the MBTCover tool and our experience from using it in multiple large test-automation projects in practice.

Other software test engineers, who conduct web application testing and MBT, may find the tool useful in their projects.

Garousi, Vahid,Keleş, Alper Buğra,Balaman, Yunus,Mermer, Alper,Güler, Zeynep Özdemir, 2024, Coverage measurement in model-based testing of web applications: Tool support and an industrial experience report

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw